Tendon sheath fibroma

Changed by Joshua Yap, 15 Oct 2022
Disclosures - updated 15 Jul 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Tendon sheath fibromas is aare rare proliferative mass,lesions with common imaging features of tenosynovial giant cell tumours.

Epidemiology

There isThey are found in adults typically between the age of 20 and 50 with a 3:1 male predominance and arise between the 2nd to 5th decades 2.

Pathology

Tendon sheath fibromas are lobulated, round-to-oval, encapsulated masses consisting of spindle cells and collagen fibres that arise from the synovium of a tendon sheath 1,2

Location

Tendon sheath fibromas can arise around 2,3:

  • small joints

    • finger (~50%)

    • hand (~25%): most commonly the flexor surface

    • wrist (~10%)

  • large joints (~5%): knee, shoulder, elbow and ankle

They can be intra-articular or extra-articular 2.

Radiographic features

MRI
  • T1:: low-to-iso signal

  • T2:: heterogeneous

  • GRE:: absent susceptibility artifact

  • T1CT1 C+ (Gd):: no or variable contrast enhancement

Treatment and prognosis

Treatment is usually surgical excision. There is a very low recurrence rate, and these tumours are not reported to have undergone malignant transformation 3.

Differential diagnosis

  • -<p><strong>Tendon sheath fibromas</strong> is a rare proliferative mass, with common imaging features of <a href="/articles/tenosynovial-giant-cell-tumour">tenosynovial giant cell tumours</a>.</p><h4>Epidemiology</h4><p>There is a 3:1 male predominance and arise between the 2nd to 5th decades <sup>2</sup>.</p><h4>Pathology</h4><p>Tendon sheath fibromas are lobulated, round-to-oval, encapsulated masses consisting of spindle cells and collagen fibres that arise from the synovium of a <a href="/articles/tendon-sheath">tendon sheath</a> <sup>1,2</sup>. </p><h5>Location</h5><p>Tendon sheath fibromas can arise around <sup>2,3</sup>:</p><ul>
  • -<li>small joints<ul>
  • -<li>finger (~50%)</li>
  • -<li>hand (~25%): most commonly the flexor surface</li>
  • -<li>wrist (~10%)</li>
  • +<p><strong>Tendon sheath fibromas</strong> are rare proliferative lesions with common imaging features of <a href="/articles/localised-tenosynovial-giant-cell-tumour-1">tenosynovial giant cell tumours</a>.</p><h4>Epidemiology</h4><p>They are found in adults typically between the age of 20 and 50 with a 3:1 male predominance <sup>2</sup>.</p><h4>Pathology</h4><p>Tendon sheath fibromas are lobulated, round-to-oval, encapsulated masses consisting of spindle cells and collagen fibres that arise from the synovium of a <a href="/articles/tendon-sheath">tendon sheath</a> <sup>1,2</sup>. </p><h5>Location</h5><p>Tendon sheath fibromas can arise around <sup>2,3</sup>:</p><ul>
  • +<li>
  • +<p>small joints</p>
  • +<ul>
  • +<li><p>finger (~50%)</p></li>
  • +<li><p>hand (~25%): most commonly the flexor surface</p></li>
  • +<li><p>wrist (~10%)</p></li>
  • -<li>large joints (~5%): knee, shoulder, elbow and ankle</li>
  • +<li><p>large joints (~5%): knee, shoulder, elbow and ankle</p></li>
  • -<li>
  • -<strong>T1</strong>: low-to-iso signal</li>
  • -<li>
  • -<strong>T2</strong>: heterogeneous</li>
  • -<li>
  • -<strong>GRE</strong>: absent <a href="/articles/magnetic-susceptibility-artifact">susceptibility artifact</a>
  • -</li>
  • -<li>
  • -<strong>T1C+</strong>: no or variable contrast enhancement</li>
  • -</ul><h4>Treatment and prognosis</h4><p>Treatment is usually surgical excision. There is a very low recurrence rate, and these tumours are not reported to have undergone malignant transformation <sup>3</sup>.</p><h4>Differential diagnosis</h4><ul>
  • -<li>
  • -<a href="/articles/tenosynovial-giant-cell-tumour">tenosynovial giant cell tumour</a>: will often show susceptibility artifact on GRE <sup>1</sup>
  • -</li>
  • -<li>
  • -<a href="/articles/nodular-fasciitis">nodular fasciitis</a> <sup>2</sup>
  • -</li>
  • +<li><p><strong>T1:</strong> low-to-iso signal</p></li>
  • +<li><p><strong>T2:</strong> heterogeneous</p></li>
  • +<li><p><strong>GRE:</strong> absent <a href="/articles/magnetic-susceptibility-artifact">susceptibility artifact</a></p></li>
  • +<li><p><strong>T1 C+ (Gd):</strong> no or variable contrast enhancement</p></li>
  • +</ul><h4>Treatment and prognosis</h4><p>Treatment is usually surgical excision. There is a very low recurrence rate and these tumours are not reported to have undergone malignant transformation <sup>3</sup>.</p><h4>Differential diagnosis</h4><ul>
  • +<li><p><a href="/articles/tenosynovial-giant-cell-tumour">tenosynovial giant cell tumour</a>: will often show susceptibility artifact on GRE <sup>1</sup></p></li>
  • +<li><p><a href="/articles/nodular-fasciitis">nodular fasciitis</a> <sup>2</sup></p></li>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.